This year, executives from nearly every major health insurance company made the same declaration in calls with Wall Street analysts: Using artificial intelligence to make coverage decisions would help save them money.<\/p>\n
Even the Trump administration is testing AI\u2019s usefulness<\/a> in managing the prior authorization process for the Medicare program, as well as seeking to override AI regulation by states.<\/p>\n But class action lawsuits have accused insurers of using AI to wrongfully withhold treatment. And new research from Stanford University<\/a> outlines the risks of training AI on a current system rife with wrongful denials.<\/p>\n \u201cThere is a world in which using AI could make that worse, or at least replicate a bad human system, because the data that it would be training on is from that bad human system,\u201d said Michelle Mello, a co-author of the study.<\/p>\n Although, Mello said, the research team found \u201creal positives alongside the risks.\u201d<\/p>\n In this video produced by KFF Health News\u2019 Hannah Norman, Darius Tahir, a correspondent covering health technology, explains.<\/p>\n You can read Tahir\u2019s recent coverage of AI\u2019s use by health insurers below:<\/p>\n \u201cRed and Blue States Alike Want To Limit AI in Insurance. Trump Wants To Limit the States<\/a>,\u201d by Darius Tahir and Lauren Sausser.<\/p>\n \u201cAI Will Soon Have a Say in Approving or Denying Medicare Treatments<\/a>,\u201d by Lauren Sausser and Darius Tahir.<\/p>\n KFF Health News<\/a> is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF\u2014an independent source of health policy research, polling, and journalism. Learn more about KFF<\/a>.<\/p>\nUSE OUR CONTENT<\/h3>\n